-
Mashup Score: 1Oncolytic Virus to Be Studied in Advanced Lung Cancer - 5 day(s) ago
The oncolytic virus, MEM-288 will be studied in combination with Opdivo for patients with non-small cell lung cancer that progressed on standard therapy.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 3
Alex Spira, MD, PhD, discusses a subset analysis of the phase 3 MARIPOSA trial looking at dose interruptions during the course of amivantamab and lazertinib treatment for EGFR-mutant non-small cell lung cancer.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4
During a Case-Based Roundtable® event, Yasir Y. Elamin, MD, discussed the intracranial efficacy of brigatinib from the ALTA-1L trial for patients with ALK+ non–small cell lung cancer in the first article of a 2-part series.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 18FDA Approval: Adjuvant Alectinib for Resected NSCLC | IASLC - 12 day(s) ago
In the wake of the FDA’s approval of alectinib for resected non-small cell lung cancer, Lung Cancer Considered host Dr. Narjust Florez and Dr. Benjamen Solomo …
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Treating Rare Driver Mutations in NSCLC: EGFR Exon 20 Insertions - 13 day(s) ago
During a Case-Based Roundtable® event, Misako Nagasaka, MD, discussed treatment for a patient with non–small cell lung cancer and an EGFR exon 20 insertion.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
Following its recent FDA approval in non-muscle-invasive bladder cancer, nogapendekin alfa has also shown overall survival benefits in addition to checkpoint inhibitor therapy in patients with non-small cell lung cancer.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 17FDA Approval: Adjuvant Alectinib for Resected NSCLC | IASLC - 22 day(s) ago
In the wake of the FDA’s approval of alectinib for resected non-small cell lung cancer, Lung Cancer Considered host Dr. Narjust Florez and Dr. Benjamen Solomo …
Source: www.iaslc.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Dato-DXd Outperforms Docetaxel in Nonsquamous Lung Cancer - 25 day(s) ago
Aaron Lisberg, MD, discussed the phase 3 TROPION-Lung01 study which evaluated datopotamab deruxtecan for patients with advanced or metastatic non-small cell lung cancer.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
The KRYSTAL-12 trial of adagrasib showed positive results for progression-free survival and tumor response in KRAS G12C-mutated non-small cell lung cancer.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1
The KRYSTAL-12 trial of adagrasib showed positive results for progression-free survival and tumor response in KRAS G12C-mutated non-small cell lung cancer.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet
A novel oncolytic virus, MEM-288, will be evaluated in the next phase of a clinical trial for patients with non-small cell lung cancer. #NSCLC #LCSM Read more here: https://t.co/UAjBwVWRNH